Pierre Fabre Boosts Oncology Offering In Europe With Puma Deal

 
• By John Davis

Another major deal with a US biotech has seen France’s Pierre Fabre exclusively licensing Puma’s Nerlynx for development and commercialization in Europe.  

Mountains
The agreement covers countries in North Africa, too. • Source: Shutterstock

More from Deals

More from Business